Guidance for Immunogen Inc. (IMGN)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2022 | N/A | N/A | $75.00M – 85.00M | $84.70M | = Maintained | Details |
| 2022 | N/A | N/A | $75.00M – 85.00M | $85.00M | = Maintained | Details |
| Q1 2022 | N/A | N/A | $75.00M – 85.00M | N/A | = Maintained | Details |
| 2021 | N/A | N/A | $65.00M – 75.00M | $69.33M | = Maintained | Details |
| Q2 2021 | N/A | N/A | $65.00M – 75.00M | $70.02M | = Maintained | Details |
| Q1 2021 | N/A | N/A | $65.00M – 75.00M | $53.10M | = Maintained | Details |
| 2020 | N/A | N/A | $60.00M – 65.00M | $63.10M | = Maintained | Details |
| Q4 2020 | N/A | N/A | $60.00M – 65.00M | $66.96M | = Maintained | Details |
| Q2 2020 | N/A | N/A | $60.00M – 65.00M | $62.72M | = Maintained | Details |
| Q1 2020 | N/A | N/A | $60.00M – 65.00M | $44.62M |  Raised |
Details |
| 2019 | N/A | N/A | $65.00M – 70.00M | $43.25M | = Maintained | Details |
| 2019 | N/A | N/A | $40.00M – 45.00M | $36.12M | = Maintained | Details |
| 2019 | N/A | N/A | $40.00M – 45.00M | $84.56M |  Lowered |
Details |
| 2018 | N/A | N/A | $50.00M – 55.00M | $57.35M | = Maintained | Details |
| Q3 2018 | N/A | N/A | $60.00M – 65.00M | $64.11M | = Maintained | Details |
| Q2 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q1 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q4 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q3 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q2 2017 | N/A | N/A | $70.00M – 75.00M | $66.15M | = Maintained | Details |
| 2014 | N/A | N/A | $71.00M – 75.00M | $71.70M | = Maintained | Details |
| 2014 | N/A | N/A | $71.00M – 75.00M | $67.13M | Raised |
Details |
